Humana Stock Price, News & Analysis (NYSE:HUM)

$271.19 +3.38 (+1.26 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$267.81
Today's Range$267.14 - $271.48
52-Week Range$203.48 - $293.35
Volume1.01 million shs
Average Volume1.16 million shs
Market Capitalization$36.68 billion
P/E Ratio22.79
Dividend Yield0.60%
Beta0.93

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Managed Health Care
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:HUM
CUSIP44485910
Phone502-580-1000

Debt

Debt-to-Equity Ratio0.48%
Current Ratio1.85%
Quick Ratio1.61%

Price-To-Earnings

Trailing P/E Ratio22.79
Forward P/E Ratio19.57
P/E Growth1.44

Sales & Book Value

Annual Sales$53.77 billion
Price / Sales0.69
Cash Flow$15.61 per share
Price / Cash17.37
Book Value$71.48 per share
Price / Book3.79

Profitability

Trailing EPS$16.68
Net Income$2.45 billion
Net Margins4.55%
Return on Equity16.13%
Return on Assets5.49%

Miscellaneous

Employees51,600
Outstanding Shares137,680,000

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Tuesday, February 6th. Stockholders of record on Friday, March 30th will be paid a dividend of $0.50 per share on Friday, April 27th. This represents a $2.00 annualized dividend and a dividend yield of 0.74%. The ex-dividend date is Wednesday, March 28th. This is a positive change from Humana's previous quarterly dividend of $0.40. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana announced that its board has initiated a share buyback program on Friday, December 15th 2017, which authorizes the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) announced its earnings results on Wednesday, February, 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.00 by $0.06. The insurance provider had revenue of $13.19 billion for the quarter, compared to analyst estimates of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.34 EPS. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY18 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of $13.50-14.00 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.45. The company issued revenue guidance of $55.8-56.4 billion, compared to the consensus revenue estimate of $56.57 billion.

Where is Humana's stock going? Where will Humana's stock price be in 2018?

18 Wall Street analysts have issued 1-year target prices for Humana's stock. Their forecasts range from $221.00 to $305.00. On average, they anticipate Humana's stock price to reach $270.29 in the next twelve months. View Analyst Ratings for Humana.

What are Wall Street analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:

  • 1. According to Zacks Investment Research, "Humana’s fourth-quarter 2017 earnings per share of $2.06 beat the Zacks Consensus Estimate but declined 12% year over year due to higher benefit expenses. Following decent 2017 results, the company provided strong guidance for 2018. Its shares have outperformed the industry in last three months.  Humana is well poised to grow on its strong government business. Its top line has been witnessing an uptrend for past many years. Sufficient generation of cash flow has helped the company take up several capital deployment initiatives aimed at enhancing shareholders’ value. Humana’s sound balance sheet and disciplined capital management remain major tailwinds. However, the company's individual commercial business has remained a drag over past few years. Rising level of expenses also continues to weigh on the bottom line." (2/12/2018)
  • 2. Cantor Fitzgerald analysts commented, "4Q17 results recap. 4Q17 revenue was $13 billion vs. our estimate of $13.8 billion and consensus of $13.2 billion. Retail segment revenue grew 3% and individual MA membership grew 1%. January 2018 individual MA membership grew about 5.7% from year end levels, which is impressive. Group MA membership grew nicely in 2017. January 2018 Group MA membership grew another 12% sequentially. MLR was slightly below our estimate and operating costs were essentially in line. 4Q17 EPS was $2.06 vs. our estimate of $1.97 and consensus of $2.00." (2/7/2018)

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:

  • Kurt J. Hilzinger, Independent Chairman of the Board (Age 57)
  • Bruce D. Broussard, President, Chief Executive Officer, Director (Age 54)
  • Brian A. Kane, Chief Financial Officer, Senior Vice President (Age 44)
  • Timothy S. Huval, Chief Human Resource Officer, Senior Vice President (Age 50)
  • Brian P. LeClaire, Senior Vice President, Chief Information Officer (Age 56)
  • Sam Deshpande, Senior Vice President, Chief Risk Officer
  • Christopher M. Todoroff, Senior Vice President, General Counsel (Age 54)
  • Roy A. Beveridge M.D., Senior Vice President, Chief Medical Officer (Age 59)
  • Jody L. Bilney, Senior Vice President, Chief Consumer Officer (Age 55)
  • Christopher H. Hunter, Senior Vice President, Chief Strategy Officer (Age 48)

Who owns Humana stock?

Humana's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.39%), Renaissance Technologies LLC (2.35%), Wells Fargo & Company MN (1.29%), Bank of New York Mellon Corp (1.13%), Geode Capital Management LLC (1.11%) and TIAA CREF Investment Management LLC (0.95%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Renaissance Technologies LLC, BlackRock Inc., Fred Alger Management Inc., American Century Companies Inc., Caisse DE Depot ET Placement DU Quebec, Old Mutual Global Investors UK Ltd. and Alliancebernstein L.P.. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was purchased by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Bank of Montreal Can, Virtus Fund Advisers LLC, Hudson Bay Capital Management LP, Wells Fargo & Company MN, NorthCoast Asset Management LLC, Teacher Retirement System of Texas and Bridger Management LLC. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of Humana stock can currently be purchased for approximately $271.19.

How big of a company is Humana?

Humana has a market capitalization of $36.68 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $16.68 on an earnings per share basis. Humana employs 51,600 workers across the globe.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.


MarketBeat Community Rating for Humana (HUM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  584 (Vote Outperform)
Underperform Votes:  676 (Vote Underperform)
Total Votes:  1,260
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Humana (NYSE:HUM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.782.682.552.63
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $270.29$258.61$251.89$243.44
Price Target Upside: 1.87% upside2.49% downside3.07% upside1.58% downside

Humana (NYSE:HUM) Consensus Price Target History

Price Target History for Humana (NYSE:HUM)

Humana (NYSE:HUM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/12/2018JPMorgan Chase & Co.Boost Price TargetNeutral -> Neutral$253.00 -> $271.00LowView Rating Details
2/9/2018Deutsche BankBoost Price TargetHold -> Hold$259.00 -> $270.00LowView Rating Details
2/8/2018OppenheimerBoost Price TargetOutperform$275.00 -> $305.00MediumView Rating Details
2/8/2018Leerink SwannBoost Price TargetOutperform -> Outperform$280.00 -> $300.00HighView Rating Details
2/8/2018Credit Suisse GroupUpgradeNeutral -> Outperform$264.90 -> $246.00MediumView Rating Details
2/7/2018Cantor FitzgeraldReiterated RatingHold$250.00MediumView Rating Details
1/12/2018Jefferies GroupUpgradeHold -> Buy$221.00MediumView Rating Details
1/3/2018Goldman Sachs GroupInitiated CoverageBuy -> Buy$305.00LowView Rating Details
12/13/2017CowenReiterated RatingBuy$285.00LowView Rating Details
11/10/2017BMO Capital MarketsBoost Price TargetOutperform$290.00 -> $300.00N/AView Rating Details
11/9/2017Morgan StanleyLower Price TargetOverweight$276.00 -> $270.00N/AView Rating Details
11/9/2017Royal Bank of CanadaReiterated RatingSector Perform -> Sector Perform$245.00 -> $242.00N/AView Rating Details
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00HighView Rating Details
7/14/2017Bank of AmericaBoost Price TargetBuy$270.00 -> $275.00LowView Rating Details
6/28/2017CitigroupInitiated CoverageBuy -> Buy$275.00MediumView Rating Details
6/9/2017ArgusUpgradeHold -> Buy$260.00LowView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/9/2017BarclaysReiterated RatingHold$217.00N/AView Rating Details
12/4/2016Susquehanna BancsharesReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Humana (NYSE:HUM) Earnings History and Estimates Chart

Earnings by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2018$3.08N/AView Earnings Details
2/7/2018Q4 2017$2.00$2.06$13.14 billion$13.19 billionViewListenView Earnings Details
11/8/2017Q3 2017$3.27$3.39$13.41 billion$13.28 billionViewN/AView Earnings Details
8/2/2017Q2 2017$3.08$3.49$13.61 billion$13.53 billionViewListenView Earnings Details
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
11/1/2010Q3 2010$1.67$2.01ViewN/AView Earnings Details
8/2/2010Q2 2010$1.63$2.11ViewN/AView Earnings Details
4/26/2010Q1 2010$1.15$1.20ViewN/AView Earnings Details
2/1/2010Q4 2009$1.48$1.48ViewN/AView Earnings Details
11/2/2009Q3 2009$1.78$1.78ViewN/AView Earnings Details
8/3/2009Q2 2009$1.65$1.67ViewN/AView Earnings Details
4/27/2009Q1 2009$1.14$1.22ViewN/AView Earnings Details
2/2/2009Q4 2008$1.07$1.07ViewN/AView Earnings Details
10/27/2008Q3 2008$1.46$1.48ViewN/AView Earnings Details
8/4/2008Q2 2008$1.18$1.24ViewN/AView Earnings Details
4/28/2008Q1 2008$0.45$0.47ViewN/AView Earnings Details
2/4/2008Q4 2007$1.32$1.43ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Humana (NYSE:HUM) Earnings Estimates

2018 EPS Consensus Estimate: $13.93
2019 EPS Consensus Estimate: $16.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$3.18$3.25$3.21
Q2 20183$4.00$4.13$4.08
Q3 20183$3.99$4.04$4.02
Q4 20183$2.44$2.83$2.62
Q1 20191$3.82$3.82$3.82
Q2 20191$4.91$4.91$4.91
Q3 20191$4.77$4.77$4.77
Q4 20191$2.99$2.99$2.99
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Humana (NYSE:HUM) Dividend Information

Next Dividend:4/27/2018
Annual Dividend:$1.60
Dividend Yield:0.59%
Dividend Growth:10.60% (3 Year Average)
Payout Ratio:9.59% (Trailing 12 Months of Earnings)
11.54% (Based on This Year's Estimates)
9.71% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Humana (NYSE:HUM)

Humana (NYSE:HUM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2018Quarterly$0.500.00189078808047194%3/28/20183/30/20184/27/2018
11/2/2017quarterly$0.400.62%12/28/201712/29/20171/26/2018
8/17/2017$0.409/28/20179/29/201710/16/2017
8/17/2017quarterly$0.400.65%9/28/20178/29/201710/27/2017
4/20/2017quarterly$0.400.75%6/28/20176/30/20177/31/2017
2/15/2017quarterly$0.400.78%3/29/20173/31/20174/28/2017
10/26/2016quarterly$0.290.67%1/10/20171/12/20171/27/2017
8/25/2016quarterly$0.290.65%10/11/201610/13/201610/28/2016
4/21/2016quarterly$0.290.66%6/28/20166/30/20167/29/2016
2/18/2016quarterly$0.290.7%3/29/20163/31/20164/29/2016
10/29/2015quarterly$0.290.65%12/28/201512/30/20151/29/2016
8/27/2015quarterly$0.290.63%9/28/20159/30/201510/30/2015
4/17/2015quarterly$0.290.65%6/26/20156/30/20157/31/2015
2/18/2015quarterly$0.280.73%3/27/20153/31/20154/24/2015
10/31/2014quarterly$0.280.81%12/29/201412/31/20141/30/2015
8/27/2014quarterly$0.280.88%9/26/20149/30/201410/31/2014
4/30/2014quarterly$0.281.02%6/26/20146/30/20147/25/2014
2/19/2014quarterly$0.271.06%3/27/20143/31/20144/25/2014
10/30/2013quarterly$0.271.17%12/27/201312/31/20131/31/2014
8/22/2013quarterly$0.271.14%9/26/20139/30/201310/25/2013
4/25/2013quarterly$0.271.47%6/26/20136/28/20137/26/2013
2/27/2013quarterly$0.261.52%3/26/20133/28/20134/26/2013
(Data available from 1/1/2013 forward)

Insider Trades

Humana (NYSE HUM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.80%
Institutional Ownership Percentage: 97.68%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)

Humana (NYSE HUM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2017Brian P LeclaireSVPSell1,679$245.97$412,983.639,888View SEC Filing  
12/19/2017Timothy S HuvalVPSell1,382$246.04$340,027.2811,557View SEC Filing  
12/18/2017Jody L BilneySVPSell7,054$247.89$1,748,616.0611,704View SEC Filing  
9/1/2017Elizabeth D BierbowerInsiderSell9,786$259.00$2,534,574.0018,042View SEC Filing  
9/1/2017Timothy S HuvalVPSell7,803$258.14$2,014,266.428,831View SEC Filing  
8/23/2017William Kevin FlemingInsiderSell3,071$250.98$770,759.587,681View SEC Filing  
8/11/2017Bruce D BroussardCEOSell12,000$251.88$3,022,560.0080,086View SEC Filing  
8/10/2017M Todoroff ChristopherVPSell22,935$252.52$5,791,546.2024,001View SEC Filing  
6/28/2017Brian P LeclaireSVPSell4,971$240.00$1,193,040.0014,258View SEC Filing  
5/26/2017Heidi S MargulisVPSell1,500$231.96$347,940.008,150View SEC Filing  
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.008,978View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42171,170View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.5423,639View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.4013,578View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.6245,635View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.453,736View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.5114,258View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.5625,734View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.8776,798View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.3618,439View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88155,108View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.716,542View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.4076,798View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.6428,577View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.1317,301View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.208,730View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.801,358View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.4789,892View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.0018,225View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.0059,944View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.101,458View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.0016,226View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.007,136View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00143,339View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.6510,801View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00154,339View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.0016,473View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33111,859View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.0010,985View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.009,327View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.0021,767View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Humana (NYSE HUM) News Headlines

Source:
DateHeadline
Humana Inc. 2017 Q4 - Results - Earnings Call SlidesHumana Inc. 2017 Q4 - Results - Earnings Call Slides
seekingalpha.com - February 22 at 4:37 PM
Heres how much last years job cuts cost HumanaHere's how much last year's job cuts cost Humana
www.bizjournals.com - February 22 at 9:21 AM
Zacks: Analysts Expect Humana Inc (HUM) Will Announce Quarterly Sales of $14.12 BillionZacks: Analysts Expect Humana Inc (HUM) Will Announce Quarterly Sales of $14.12 Billion
www.americanbankingnews.com - February 19 at 9:00 AM
 Analysts Anticipate Humana Inc (HUM) Will Post Earnings of $3.21 Per Share Analysts Anticipate Humana Inc (HUM) Will Post Earnings of $3.21 Per Share
www.americanbankingnews.com - February 17 at 1:16 AM
Can Solid Retail Segment Drive Humanas (HUM) Q4 Earnings?Can Solid Retail Segment Drive Humana's (HUM) Q4 Earnings?
finance.yahoo.com - February 16 at 4:34 PM
Humana Inc (HUM) Files 10-K for the Fiscal Year Ended on December 31, 2017Humana Inc (HUM) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 16 at 4:34 PM
Omega Advisors 13F Shows New Stake in Humana (HUM), Wells Fargo (WFC), Gold ETF (GLD), Sells AET (AET ... - StreetInsider.comOmega Advisors 13F Shows New Stake in Humana (HUM), Wells Fargo (WFC), Gold ETF (GLD), Sells AET (AET ... - StreetInsider.com
www.streetinsider.com - February 15 at 6:31 AM
Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely - TheStreet.comWhy a Walgreens Purchase of Humana or WellCare Now Appears Less Likely - TheStreet.com
www.thestreet.com - February 14 at 3:26 PM
Health Leaders Cite Limited Ability to Share Clinical Information as ... - GlobeNewswire (press release)Health Leaders Cite Limited Ability to Share Clinical Information as ... - GlobeNewswire (press release)
globenewswire.com - February 14 at 6:28 AM
Health Leaders Cite Limited Ability to Share Clinical Information as Key Obstacle to Value-Based PaymentHealth Leaders Cite Limited Ability to Share Clinical Information as Key Obstacle to Value-Based Payment
feeds.benzinga.com - February 13 at 10:34 AM
Humana (HUM) Price Target Increased to $271.00 by Analysts at JPMorgan Chase & Co.Humana (HUM) Price Target Increased to $271.00 by Analysts at JPMorgan Chase & Co.
www.americanbankingnews.com - February 12 at 8:28 PM
Humana (HUM) Lifted to "Buy" at Zacks Investment ResearchHumana (HUM) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - February 12 at 10:08 AM
Analysts Offer Predictions for Humana Incs FY2019 Earnings (HUM)Analysts Offer Predictions for Humana Inc's FY2019 Earnings (HUM)
www.americanbankingnews.com - February 12 at 8:58 AM
FY2018 EPS Estimates for Humana Inc Lowered by Jefferies Group (HUM)FY2018 EPS Estimates for Humana Inc Lowered by Jefferies Group (HUM)
www.americanbankingnews.com - February 12 at 6:18 AM
Humana Inc (HUM) Forecasted to Post FY2018 Earnings of $14.00 Per ShareHumana Inc (HUM) Forecasted to Post FY2018 Earnings of $14.00 Per Share
www.americanbankingnews.com - February 12 at 6:18 AM
Q2 2018 EPS Estimates for Humana Inc (HUM) Boosted by AnalystQ2 2018 EPS Estimates for Humana Inc (HUM) Boosted by Analyst
www.americanbankingnews.com - February 12 at 3:46 AM
Humana (HUM) Upgraded by Credit Suisse Group to OutperformHumana (HUM) Upgraded by Credit Suisse Group to Outperform
www.americanbankingnews.com - February 11 at 2:12 PM
Humana and Veterans of Foreign Wars (VFW) Enhance Efforts to ... - Business Wire (press release)Humana and Veterans of Foreign Wars (VFW) Enhance Efforts to ... - Business Wire (press release)
www.businesswire.com - February 10 at 6:32 AM
See what the IHS Markit Score report has to say about Humana Inc.See what the IHS Markit Score report has to say about Humana Inc.
finance.yahoo.com - February 10 at 6:31 AM
Humana (HUM) Given New $270.00 Price Target at Deutsche BankHumana (HUM) Given New $270.00 Price Target at Deutsche Bank
www.americanbankingnews.com - February 10 at 12:52 AM
Brokers Offer Predictions for Humana Incs Q1 2018 Earnings (HUM)Brokers Offer Predictions for Humana Inc's Q1 2018 Earnings (HUM)
www.americanbankingnews.com - February 9 at 8:26 AM
Humana Inc to Post Q1 2018 Earnings of $3.21 Per Share, Jefferies Group Forecasts (HUM)Humana Inc to Post Q1 2018 Earnings of $3.21 Per Share, Jefferies Group Forecasts (HUM)
www.americanbankingnews.com - February 9 at 8:26 AM
Equities Analysts Issue Forecasts for Humana Incs Q1 2018 Earnings (HUM)Equities Analysts Issue Forecasts for Humana Inc's Q1 2018 Earnings (HUM)
www.americanbankingnews.com - February 9 at 8:26 AM
UPDATE 3-Humana profit tops estimates; sees $550 mln tax benefitUPDATE 3-Humana profit tops estimates; sees $550 mln tax benefit
www.cnbc.com - February 9 at 6:28 AM
Credit Suisse: Growing Enrollment, 2019 Tailwinds For Humana Justify Bullish StanceCredit Suisse: Growing Enrollment, 2019 Tailwinds For Humana Justify Bullish Stance
finance.yahoo.com - February 9 at 6:28 AM
Leerink Swann Boosts Humana (HUM) Price Target to $300.00Leerink Swann Boosts Humana (HUM) Price Target to $300.00
www.americanbankingnews.com - February 8 at 6:40 PM
Oppenheimer Increases Humana (HUM) Price Target to $305.00Oppenheimer Increases Humana (HUM) Price Target to $305.00
www.americanbankingnews.com - February 8 at 4:22 PM
Humana swings to profit on retail boostHumana swings to profit on retail boost
www.marketwatch.com - February 8 at 3:24 PM
Humana (HUM) Tops Q4 Earnings & Revenues, Issues 18 ViewHumana (HUM) Tops Q4 Earnings & Revenues, Issues '18 View
www.zacks.com - February 8 at 3:24 PM
Humana Inc Q4 Profit FallsHumana Inc Q4 Profit Falls
www.nasdaq.com - February 8 at 3:24 PM
Humana???s (HUM) Q4 Earnings Surpass ExpectationsHumana???s (HUM) Q4 Earnings Surpass Expectations
finance.yahoo.com - February 8 at 3:24 PM
Humana and Veterans of Foreign Wars (VFW) Enhance Efforts to Drive Optimal Health for VeteransHumana and Veterans of Foreign Wars (VFW) Enhance Efforts to Drive Optimal Health for Veterans
finance.yahoo.com - February 8 at 3:24 PM
Humana Reports Fourth Quarter 2017 Financial Results; Provides 2018 Financial Guidance - Business Wire (press release)Humana Reports Fourth Quarter 2017 Financial Results; Provides 2018 Financial Guidance - Business Wire (press release)
www.businesswire.com - February 8 at 6:19 AM
Humana (HUM) Tops Q4 Earnings & Revenues, Issues 18 View - NasdaqHumana (HUM) Tops Q4 Earnings & Revenues, Issues '18 View - Nasdaq
www.nasdaq.com - February 8 at 6:19 AM
Humana to consolidate clinics into new company, beats on 4Q EPS, revenue - Louisville Business FirstHumana to consolidate clinics into new company, beats on 4Q EPS, revenue - Louisville Business First
www.bizjournals.com - February 8 at 6:19 AM
Humana Inc Earnings Report Didnt Answer the Right Questions - Investorplace.comHumana Inc Earnings Report Didn't Answer the Right Questions - Investorplace.com
investorplace.com - February 8 at 6:19 AM
Humanas quarterly profit, 2018 forecast top estimatesHumana's quarterly profit, 2018 forecast top estimates
finance.yahoo.com - February 8 at 6:19 AM
Humana Inc (NYSE:HUM): Time For A Financial Health CheckHumana Inc (NYSE:HUM): Time For A Financial Health Check
finance.yahoo.com - February 8 at 6:19 AM
Humana profit tops estimates; sees $550 mln tax benefitHumana profit tops estimates; sees $550 mln tax benefit
finance.yahoo.com - February 8 at 6:19 AM
Humana (HUM) Tops Q4 Earnings & Revenues, Issues '18 ViewHumana (HUM) Tops Q4 Earnings & Revenues, Issues '18 View
finance.yahoo.com - February 8 at 6:19 AM
Humanas Senior-Focused Doctor Strategy Boosts Medicare Advantage SalesHumana's 'Senior-Focused' Doctor Strategy Boosts Medicare Advantage Sales
finance.yahoo.com - February 8 at 6:19 AM
Humana to consolidate clinics into new company, beats on 4Q EPS, revenueHumana to consolidate clinics into new company, beats on 4Q EPS, revenue
finance.yahoo.com - February 8 at 6:19 AM
Humana (HUM) Stock Rating Reaffirmed by Cantor FitzgeraldHumana (HUM) Stock Rating Reaffirmed by Cantor Fitzgerald
www.americanbankingnews.com - February 8 at 12:14 AM
Humana Inc Earnings Report Didn’t Answer the Right QuestionsHumana Inc Earnings Report Didn’t Answer the Right Questions
investorplace.com - February 7 at 1:45 PM
Humana (HUM) Posts Quarterly  Earnings Results, Beats Estimates By $0.06 EPSHumana (HUM) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS
www.americanbankingnews.com - February 7 at 9:10 AM
Humana (HUM) Updates FY18 Earnings GuidanceHumana (HUM) Updates FY18 Earnings Guidance
www.americanbankingnews.com - February 7 at 9:02 AM
Earnings Scheduled For February 7, 2018 - BenzingaEarnings Scheduled For February 7, 2018 - Benzinga
www.benzinga.com - February 7 at 6:25 AM
Humana beats Street 4Q forecastsHumana beats Street 4Q forecasts
finance.yahoo.com - February 7 at 6:25 AM
Health care stocks drop premarket, setting sector up for second consecutive day of declines - MarketWatchHealth care stocks drop premarket, setting sector up for second consecutive day of declines - MarketWatch
www.marketwatch.com - February 6 at 3:23 PM
Can Solid Retail Segment Drive Humanas (HUM) Q4 Earnings? - NasdaqCan Solid Retail Segment Drive Humana's (HUM) Q4 Earnings? - Nasdaq
www.nasdaq.com - February 5 at 3:23 PM

SEC Filings

Humana (NYSE:HUM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Humana (NYSE:HUM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Humana (NYSE HUM) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.